Current Enterprise Value (EV)
Current share price (P) | $200.88 |
No. shares of common stock outstanding | 1,765,354,859 |
US$ in millions | |
Common equity (market value)1 | 354,624) |
Add: Noncontrolling interest (per books) | 39) |
Total equity | 354,663) |
Add: Short-term borrowings (per books) | —) |
Add: Current portion of long-term debt and finance lease obligations (per books) | 6,804) |
Add: Long-term debt and finance lease obligations, excluding current portion (per books) | 60,340) |
Total equity and debt | 421,807) |
Less: Cash and equivalents | 5,524) |
Less: Short-term investments | 31) |
Enterprise value (EV) | 416,252) |
Based on: 10-K (reporting date: 2024-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 200.88 × 1,765,354,859
Historical Enterprise Value (EV)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of AbbVie Inc. Annual Report.
3 2024 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 192.87 × 1,765,354,859
Item | Description | The company |
---|---|---|
EV | Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. | AbbVie Inc. EV increased from 2022 to 2023 and from 2023 to 2024. |